Related Experiment Videos
The content and context of compliance
1MRC Social and Community Psychiatry Unit, Institute of Psychiatry, De Crespigny Park, London, UK.
International Clinical Psychopharmacology
|January 1, 1995
Summary
Patient adherence to schizophrenia treatment, particularly neuroleptics, is crucial. Improving patient-doctor relationships and providing information significantly enhances treatment compliance.
Area of Science:
- Psychiatry
- Clinical Psychology
- Pharmacology
Background:
- Non-compliance with prescribed treatments affects up to 50% of patients with schizophrenia.
- Demographic factors have minimal impact, but clinical features like positive symptoms and dual diagnosis (especially alcohol abuse) are associated with non-compliance.
Purpose of the Study:
- To explore factors influencing treatment compliance in schizophrenia.
- To identify strategies for improving adherence to neuroleptic treatment.
Main Methods:
- Review of factors influencing patient adherence.
- Analysis of the health belief model and patient-doctor relationship in treatment adherence.
- Examination of techniques to improve compliance.
Main Results:
- Patient and relative beliefs about schizophrenia and medication are significant determinants of compliance.
- A strong therapeutic relationship, provision of information, and consistent support are key to improving adherence.
- Effective compliance strategies involve fostering productive views of illness and medication.
Conclusions:
- Improving treatment compliance in schizophrenia requires a multifaceted approach focusing on patient beliefs and the therapeutic alliance.
- Addressing non-compliance is essential for reducing the burden on patients and society.
- Effective strategies are vital for optimal schizophrenia management.